ALC:NYSE
Alcon AG
69,66 USD
arrow_upward
+4,25%(+2,84) 1D
69,66 USD
0,00% (0,00)
bedtimeAfter hours
Closed: 2-июл., 16:00:07 GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ALC...
Open
67,61 USD
High
69,74 USD
Low
67,53 USD
Mkt. cap
27,30 млд
Avg. vol.
2,06 млн
Volume
1,90 млн
52-wk high
92,55 USD
52-wk low
61,84 USD
Beta
0,88
Shares outstanding
487,70 млн
No. of employees
25 миң
Open
67,61 USD
High
69,74 USD
Low
67,53 USD
Mkt. cap
27,30 млд
Avg. vol.
2,06 млн
Volume
1,90 млн
52-wk high
92,55 USD
52-wk low
61,84 USD
Beta
0,88
Shares outstanding
487,70 млн
No. of employees
25 миң
News stories
From sources across the web
AD HOC NEWS
·
7 саат мурун
Alcon stock holds its footing. Focus turns to the eye-care model.
Stock Traders Daily
·
7 саат мурун
Avoiding Lag: Real-Time Signals in (ALC) Movement
Yahoo Finance
·
3 күн мурун
Is it a Prudent Move to Retain ALC Stock in Your Portfolio Now?
Profile
Alcon Inc. is a Swiss-American pharmaceutical and medical device company specializing in eye care products. Alcon is incorporated in the Canton of Fribourg, Switzerland, and its global headquarters are located in Geneva, but its main operational base is in Fort Worth, Texas, United States, where it employs about 4,500 people.
Alcon was a subsidiary of Novartis until April 2019, when it was spun out into a separate publicly traded company. Alcon itself has a number of subsidiaries, including Aerie Pharmaceuticals, focused on therapies for glaucoma and other diseases of the eye, and WaveLight, which develops and manufactures laser eye surgery technologies. Wikipedia
About Alcon AG
CEODavid J. Endicott
Employees25 миң
Founded1945
HeadquartersЖенева, Женева, Швейцария
SectorMedical device
Websitealcon.com
AI content may include mistakes. Learn more